NCT07143110 LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada
| NCT ID | NCT07143110 |
| Status | Recruiting |
| Phase | — |
| Sponsor | AstraZeneca |
| Condition | Lung Neoplasms |
| Study Type | OBSERVATIONAL |
| Enrollment | 60,000 participants |
| Start Date | 2025-08-20 |
| Primary Completion | 2027-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60,000 participants in total. It began in 2025-08-20 with a primary completion date of 2027-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
LUNG-ROLL is a retrospective cohort study that will describe the contemporary treatment patterns, prevalence and incidence, patient demographic and clinical characteristics, clinical outcomes, and healthcare resource use/costs for patients with lung cancer in Canada (specifically, Alberta and Ontario) using administrative data.
Eligibility Criteria
Inclusion Criteria: * Patients with lung cancer between January 1, 2018 and end of the Selection Period. * Patient is 18 years of age or older on diagnosis date. * Patient has at least 12 months of health insurance coverage prior to the diagnosis date. Exclusion Criteria: * Diagnosed with any other cancer in the 5-year period prior to January 1, 2018. * Diagnosed with any other cancer concurrently (i.e., on the same date) as lung cancer diagnosis. * Invalid or incomplete records for key variables (e.g., missing year of diagnosis, missing cancer type). * Non-Ontario or non-Alberta resident on diagnosis date.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07143110 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 130 Years, studying Lung Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07143110 currently recruiting?
Yes, NCT07143110 is actively recruiting participants. Contact the research team at information.center@astrazeneca.com for enrollment information.
Where is the NCT07143110 trial being conducted?
This trial is being conducted at Calgary, Canada, Toronto, Canada.
Who is sponsoring the NCT07143110 clinical trial?
NCT07143110 is sponsored by AstraZeneca. The trial plans to enroll 60,000 participants.